Healthpeak Properties DOC Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $752.95M+7.1% | $719.4M+3.1% | $705.87M+0.8% | $694.35M-0.2% | $702.89M+15.9% | ||
| —— | —— | $413.95M-1.5% | $418.17M-0.8% | $429.75M+18.4% | ||
| $24.59M-5.8% | $23.63M-1.3% | $19.91M-14.3% | $20.76M-22.3% | $26.12M+12.1% | ||
| $747.35M+16.3% | $660.78M-1.1% | $653.3M-1.8% | $651.64M-2.2% | $642.47M-3.5% | ||
| $87.29M+20.1% | $80.64M+14.4% | $76.78M+3.6% | $75.06M+0.2% | $72.69M+19.4% | ||
| $190.05M+3,202% | $66.49M— | $12.66M-80.0% | -$3.06M-102% | -$6.13M-107% | ||
| $195.65M+260% | $125.11M— | $65.24M-33.8% | $39.65M-74.5% | $54.29M+141% | ||
| $254K-87.8% | $6.03M— | -$1.21M-162% | $2.38M-12.7% | $2.08M-84.8% | ||
| $193.63M+352% | $113.97M+2,406% | -$117.12M-236% | $31.67M-78.3% | $42.83M+542% | ||
| 25.7%+19.6pp | 15.8%+15.2pp | -16.6%-28.9pp | 4.6%-16.4pp | 6.1%+5.0pp | ||
| $0.28+367% | $0.16+700% | -$0.17-242% | $0.05-76.2% | $0.06+500% | ||
| $572.67M+44.8% | $467.84M+35.6% | $404.34M-10.7% | $380.63M-25.9% | $395.53M+30.7% | ||
| 76.1%+19.8pp | 65%+15.6pp | 57.3%-7.3pp | 54.8%-19.1pp | 56.3%+6.4pp | ||
| $282.94M+123% | $205.75M+192% | $142.02M-17.7% | $114.72M-50.2% | $126.98M+52.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Healthpeak Properties's revenue?
- Healthpeak Properties (DOC) generated $2.9B in revenue over the trailing twelve months, up 2.7% year over year.
- Is Healthpeak Properties profitable?
- Healthpeak Properties reported $222.2M in net income over the trailing twelve months, a 7.7% net margin.
- What is Healthpeak Properties's earnings per share?
- Healthpeak Properties's diluted EPS over the trailing twelve months is $0.32.
- Where does Healthpeak Properties's income statement data come from?
- Every line is extracted from Healthpeak Properties's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
